Abstract
In an effort to improve symptom palliation, palliative thoracic radiotherapy (TRT) has been integrated into various palliative approaches in patients with advanced non-small cell lung cancer (NSCLC). Palliative TRT can effectively palliate locoregional symptoms like haemoptysis, cough, shortness of breath, chest pain. Palliative TRT can be given using both hypofractionated and multifractionated regimens. Hypofractionated regimens are convenient to deliver and also cost-effective. Furthermore, hypofractionated palliative TRT may release radiotherapy sources and make radiotherapy more available for other groups of cancer patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
